193 related articles for article (PubMed ID: 6189039)
41. [Chemotherapy of lung cancer].
Dement'eva NP
Sov Med; 1984; (11):55-61. PubMed ID: 6084308
[No Abstract] [Full Text] [Related]
42. [Combination chemotherapy in patients with disseminated bronchogenic carcinoma (author's transl)].
Gropp C; Havemann K; Gassel WD; Hess F; Prignitz R; Schmidt M; Sodomann CP
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1977 Dec; 90(3):301-6. PubMed ID: 146331
[TBL] [Abstract][Full Text] [Related]
43. Chemotherapy for inoperable, non-small cell bronchogenic carcinoma: EST 2575, generation II.
Ruckdeschel JC; Mehta CR; Salazar OM; Cohen M; Vogl S; Koons LS; Lerner H
Cancer Treat Rep; 1981; 65(11-12):965-72. PubMed ID: 7028258
[TBL] [Abstract][Full Text] [Related]
44. Combination chemotherapy of advanced lung cancer: a randomized trial.
Hansen HH; Selawry OS; Simon R; Carr DT; van Wyk CE; Tucker RD; Sealy R
Cancer; 1976 Dec; 38(6):2201-7. PubMed ID: 187312
[TBL] [Abstract][Full Text] [Related]
45. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
Dundalek E
Prax Klin Pneumol; 1980 Dec; 34(12):719-23. PubMed ID: 7465532
[No Abstract] [Full Text] [Related]
46. [Results of a sequential polychemotherapy (adriamycin, vincristine, cyclophosphamide, methotrexate) in small-cell and undifferentiated bronchial cancer].
Taytard A; Chomy P; Courty G; Gachie JP; Roquain J
Rev Fr Mal Respir; 1980; 8(3):225-32. PubMed ID: 6314444
[TBL] [Abstract][Full Text] [Related]
47. [Chemotherapy of bronchopulmonary cancer. Trial of the BACON protocol].
Adenis L; Restellini J; Caty A
LARC Med; 1981 Nov; 1(2):50-1. PubMed ID: 6188012
[No Abstract] [Full Text] [Related]
48. [Evaluation of the results of chemotherapy in squamous cell bronchial carcinoma].
Nagorni-Obradović L
Med Pregl; 1991; 44(9-10):387-90. PubMed ID: 1806789
[TBL] [Abstract][Full Text] [Related]
49. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
Aisner J; Whitacre M; Van Echo DA; Wiernik PH
Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
[TBL] [Abstract][Full Text] [Related]
50. Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (CAMP) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: a prospective study.
Trovò MG; Tirelli U; De Paoli A; Franchin G; Roncadin M; Magri M; Galligioni E; Veronesi A; Tumolo S; Carbone A; Grigoletto E
Int J Radiat Oncol Biol Phys; 1982 Jun; 8(6):1051-4. PubMed ID: 7107434
[TBL] [Abstract][Full Text] [Related]
51. Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.
Livingston RB
Cancer Treat Rev; 1977 Sep; 4(3):153-65. PubMed ID: 73419
[No Abstract] [Full Text] [Related]
52. Neoadjuvant chemotherapy in early-stage and locally advanced small bulk squamous cell carcinoma of the oral cavity and oropharynx.
Tichler T; Ramon Y; Rath P; Hendler S; Brenner HJ
Isr J Med Sci; 1988; 24(9-10):539-44. PubMed ID: 2462551
[TBL] [Abstract][Full Text] [Related]
53. Combination chemotherapy in inoperable lung cancer--a trial of 2 regimens.
Behera D; Malik SK
Indian J Chest Dis Allied Sci; 1989; 31(1):21-4. PubMed ID: 2509339
[TBL] [Abstract][Full Text] [Related]
54. Chemotherapy for lung cancer.
Golbey RB
Postgrad Med; 1978 Feb; 63(2):137-41. PubMed ID: 75540
[TBL] [Abstract][Full Text] [Related]
55. [Chemotherapy in bronchogenic carcinoma (author's transl)].
Bruntsch U
Rontgenblatter; 1977 Apr; 30(4):196-201. PubMed ID: 67629
[TBL] [Abstract][Full Text] [Related]
56. Combination chemotherapy with bleomycin (NSC-125066), vincristine (NSC-67574), and methotrexate (NSC-740) plus split-course radiotherapy in the treatment of non-oat-cell bronchogenic carcinoma.
Samuels ML; Barkley HT; Holoye PY; Rosenberg PJ; Smith TL
Cancer Chemother Rep; 1975; 59(2 Pt 1):377-83. PubMed ID: 50124
[TBL] [Abstract][Full Text] [Related]
57. Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancer.
Pearlman NW; Meyers TJ; Siebert PE; Wallner SF; Carson SD; Campbell DN; Johnson FB; Kennaugh R; Rempel P
Cancer Treat Rep; 1983 Apr; 67(4):375-6. PubMed ID: 6303587
[TBL] [Abstract][Full Text] [Related]
58. CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lung.
Cambareri RJ; Smith FP; Macdonald JS; Haidak DJ; Ueno WM; Hoth DH; Woolley PV; Schein PS
Cancer Treat Rep; 1981; 65(3-4):317-20. PubMed ID: 6263471
[No Abstract] [Full Text] [Related]
59. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
Perevodchikova NI; Bychkov MB
Cancer Chemother Rep 3; 1973 Mar; 4(2):251-5. PubMed ID: 4199645
[No Abstract] [Full Text] [Related]
60. Methotrexate in the chemotherapy of lung cancer.
Smyth JF; Ford HT
Cancer Treat Rep; 1981; 65 Suppl 1():161-3. PubMed ID: 6275986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]